Trial intelligence / Profile preview

ORG 28611 vs Morphine in Dental Pain

NCT00782951Phase 2Terminated

Sponsor
Merck & Co.
Start
Jul 2007
Primary completion
Aug 2007
Modality
Orthosteric Ligands
01

Overview

Phase 2, randomised, double-blind trial of Org 28611 in postoperative pain (3 arms), sponsored by Merck & Co. Primary endpoint: Total Pain Relief Score. Started Jul 2007; status: terminated.

02

Drugs

Org 28611
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT00782951.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00782951.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call